Stocks hitting fresh highs can either signal that a stock is on its way to greatness or that it has run its course. Even with the risk of the latter, searching for these outperformers can reveal companies that are doing something right, much to their investors' delight.

I'm a poet and didn't know it
With that in mind, we'll use the aggregate intelligence of the 110,000-plus investors participating in Motley Fool CAPS to find stocks hitting 52-week highs today. The community's approval (those with four- and five-star ratings) could be a sign that further research is in order.

Here are three such stocks:

 

Today’s High

Industry

CAPS Rating

Fools Saying Outperform

Myriad Genetics, Inc. (NYSE:MYGN)

$63.80

Drugs

***

200 of 226

Teledyne Technologies, Inc. (NYSE:TDY)

$64.94

Aerospace/Defense

*****

215 of 221

Nabi Biopharmaceuticals (NASDAQ:NABI)

$5.19

Drugs

*****

99 of 107

Source: Motley Fool CAPS, as of July 25.

Other Five-Star Aerospace/Defense Companies

Raytheon Company (NYSE:RTN) -- up 4.3% in the past year.
Triumph Group (NYSE:TGI) -- stock price is 35% cheaper than a year ago.

Other Five-Star Drug Companies

Meridian Bioscience (NASDAQ:VIVO) -- up 12.8% in the past year.
Simcere Pharmaceutical Group (NYSE:SCR) -- stock price is 8.6% cheaper than a year ago.

Come and join us on CAPS to learn more about these and countless other interesting stock ideas. Click here to sign up.

Fool Analyst Dan Dzombak wishes he had bought these stocks last year. Unfortunately, he does not have a financial position in any of the stocks mentioned in this article. Myriad Genetics is a Motley Fool Rule Breakers recommendation. Try any of our Foolish newsletters today, free for 30 days.  The Motley Fool has a disclosure policy.